AlphaFold predicted structure
TGFB1 · P01137

Mean pLDDT
79.6/ 100
Confident
390 residues
Confidence breakdown
- Very high(≥ 90)40%
- Confident(70–90)32%
- Low(50–70)21%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transforming growth factor beta 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownOsteopetrosis
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownCamurati-Engelmann disease
inflammatory bowel disease, immunodeficiency, and encephalopathy
myelodysplastic syndrome
anemia
cancer
anemia (phenotype)
Beta-thalassemia
Encephalopathy
IL10-related early-onset inflammatory bowel disease
cystic fibrosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transforming growth factor beta-1 proprotein
Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively
TGFB1 · P01137

Mean pLDDT
79.6/ 100
Confident
390 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0